Battlefield 6’s Campaign Unveiled at State of Play Sony’s September State of Play event gave gamers their first-ever look at the Battlefield 6 single-player campaign. During the livestream, a new story trailer for BF6 was one of the show’s headline reveals notebookcheck.net. The footage (now available on YouTube) offers a glimpse into the game’s cinematic ambitions, blending fast-cut gameplay with narrative scenes. It opens with Dagger 13 operators executing a synchronized takedown, and then erupts into a montage of global combat set-pieces gamespot.com. In one moment we see the player character sprinting through a bombed-out Brooklyn neighborhood under heavy fire; the next,

Stock Split Announcement Sets Off a Market Surge Tata Investment Corporation’s stock spiked dramatically in late September 2025, immediately after the company confirmed its long-awaited stock split was moving forward. On September 22, the firm informed exchanges that shareholders had approved a 1:10 stock split (sub-dividing each ₹10 share into ten ₹1 shares) and set a record date of October 14 for this corporate action business-standard.com. This news acted as a catalyst for the stock: on September 23 and 24, TICL shares rocketed roughly 25% in value, reaching all-time highs around ₹9,100 apiece businesstoday.in. The rally was striking not just

Acadia Healthcare (ACHC) Stock and News Overview as of September 24, 2025 Stock Performance: Fall and Rebound in 2025 Acadia Healthcare’s stock has been on a rollercoaster. As of September 24, 2025, ACHC traded around the mid-$20s per share after a sudden spike in the wake of activist investor news reuters.com. This rally – nearly a 9% jump in one afternoon – offered relief to shareholders who had endured a prolonged slide. Before the late-September rebound, Acadia’s stock was down roughly 41% year-to-date in 2025 investing.com and hovering near multi-year lows. The stock’s swoon followed a series of setbacks (operational

Cidara Therapeutics (CDTX) Stock and Company Update as of September 24, 2025 Stock Performance & Technical Analysis Cidara’s stock has been on a tear in 2025, delivering triple-digit percentage gains. Year-to-date, CDTX has risen about +173% as of late September investing.com, driven by upbeat trial results and investor enthusiasm for its flu program. The stock recently surged over 20% in one day after the Phase 3 acceleration news, reaching an intraday high of approximately $87.75 on Sept. 24 marketbeat.com marketbeat.com. This is effectively a new 52-week (and all-time) high, far above its 52-week low of ~$10 marketbeat.com. By comparison, Cidara’s market capitalization now stands around $2.0–2.3 billion at these prices